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Background. Large body size can cause a higher proportion of emitted photons being
attenuated within the patient. Therefore, clinical myocardial perfusion SPECT (MPS) protocols
often include unproportionally higher radioisotope activity to obese patients. The aim was to
evaluate if a linear weight-adjusted low-dose protocol can be applied to obese patients and
thereby decrease radiation exposure.
Methods and result. Two hundred patients (>110 kg, BMI 18-41, [n 5 69], £ 110 kg, BMI
31-58, [n 5 131]) underwent 99mTc-tetrofosmin stress examination on a Cadmium Zinc Tel-
luride or a conventional gamma camera using new generations of reconstruction algorithm
(Resolution Recovery). Patients <110 kg were administered 2.5 MBq/kg, patients between 110
and 120 kg received 430 MBq and patients >120 kg received 570 MBq according to clinical
routine. Patients >110 kg had 130% total number of counts in the images compared to
patients <110 kg. Recalculating the counts to correspond to an administered activity of
2.5 MBq/kg resulted in similar number of counts across the groups. Image analyses in a sub-
group with images corresponding to high activity and 2.5 MBq/kg showed no difference in
image quality or ischemia quantification.
Conclusion. Linear low-dose weight-adjusted protocol of 2.5 MBq/kg in MPS can be
applied over a large weight span without loss of counts or image quality, resulting in a sig-
nificant reduction in radiation exposure to obese patients. (J Nucl Cardiol 2016)
Key Words: Myocardial perfusion imaging: SPECT Æ CZT detector Æ conventional gamma
camera Æ image quality Æ radiation dose
INTRODUCTION
Ischemic heart disease (IHD) is one of the most
common causes of death in the western world1 and a
major cause of heart failure.2 Presence of stress-induced
myocardial ischemia due to significant coronary stenosis
has been shown to be of fundamental clinical impor-
tance for patient prognosis3,4 and need for
revascularization therapy.5 Current ESC/EACTS (Euro-
pean Society of Cardiology/European Association for
Cardio-thoracic Surgery) guidelines6 therefore strongly
recommend having a stress examination performed in
patients with suspected stable coronary artery disease
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(CAD) before decision for revascularization therapy is
taken.
Myocardial perfusion single-photon emission com-
puted tomography (MPS) is a well-established
noninvasive imaging technique for detection of myocar-
dial ischemia. Recently, a new generation of gamma
camera systems was introduced based on a novel
detector technology utilizing semiconductor detectors
of Cadmium Zinc Telluride (CZT).7,8 Furthermore, a
new generation of reconstruction methods for the
conventional gamma cameras was recently introduced
referred to as Ordered Subset Expectation Maximization
with depth-dependent Resolution Recovery (OSEM-
RR).9 Both CZT detectors and OSEM-RR can be used
to reduce the radiation exposure to nonobese
patients10–12 in accordance with ALARA (As Low As
Reasonably Achievable).13
A large body size may cause a higher proportion of
emitted photons being attenuated and scattered within
the patient resulting in reduced number of primary
photons reaching the detector. In order to compensate
for this, clinical protocols often include administration
of proportionally higher radioisotope activity to patients
with higher body weight in accordance with American
Society of Nuclear Cardiology (ASNC) guidelines,14
whereas others recommend a fixed dose to all patients
regardless of weight.15 Both strategies result in a large
variation in absorbed dose with potentially unnecessary
high radiation exposure to patients with overweight/
obesity and low body weight, respectively. Body mass
index (BMI) is an index of weight-for-height that is
commonly used to classify overweight and obesity in
adults. The World Health Organization (WHO) defini-
tion is as follows: a BMI C25 is overweight and a
BMI C30 is obesity.
We have previously demonstrated that the new CZT
technology enables a radiation dose reduction in
nonobese patients by implementing a low-dose protocol,
2.5 MBq/kg body weight.12 Other studies have also
demonstrated the possibility of low-dose protocol using
new CZT technology or new generation of reconstruc-
tion algorithms OSEM-RR on conventional gamma
cameras in nonobese patients.16–20 A recent study
indicates the possibility of dose reduction also for obese
patients with a fixed activity using the CZT
technology.21
The aim of the present study was to evaluate
whether a similar linear administration schedule can be
extended to all adult patients, not only nonobese, on
both CZT cameras and conventional gamma cameras
using resolution recovery reconstruction, in order to
enable a decrease in radiation exposure to obese
patients.
MATERIALS AND METHODS
Study Population and Study Design
The study included 200 patients referred for MPS due to
known or suspected coronary artery disease. All patients
underwent a 99mTc-tetrofosmin stress examination, according
to clinical routine. The stress was accomplished either by a
bicycle ergometer test or pharmacologic stress. The amount of
radioisotope was administered according to body weight for
patients below 110 kg (2.5 MBq/kg). According to clinical
routine, a fixed activity of 430 and 570 MBq ± 10% was used
for patients between 110 and 120 kg and above 120 kg,
respectively. The syringe was measured before and after
injection of 99mTc-tetrofosmin to calculate the specific admin-
istered activity. A subset of the included patients with a body
weight over 110 kg were also scanned with a reduced
acquisition time corresponding to an injected activity of
2.5 MBq/kg of body weight.
Rest examination was performed if the stress examination
images were interpreted as abnormal. The rest examination
was undertaken according to a predefined, in-house developed
time schedule designed to meet the ASNC recommended
guidelines of 3 times more activity in the rest examination in a
1-day protocol for patients\120 kg. Thus, individually
adjusted activity was administered at rest depending on the
duration between the two examinations, with a minimum of
2 hours, resulting in decreased activity with increased dura-
tion. Patients[120 kg was examined with a two-day protocol
since the total activity otherwise would exceed what the
Swedish regulations allow for MPS.
The number of counts in the left ventricle was analyzed on
all images, and on a subset of images the perceived quality as
well as a quantitative diagnostic analysis was performed. All
patients provided written informed consent to participate in the
study and the study was approved by the regional ethics
committee.
Image Acquisition and Reconstruction
The scan was performed approximately 1 hour after the
injection with either a CZT gamma camera (Discovery NM
530c, GE Healthcare) or a conventional gamma camera
(Ventri, GE Healthcare) dedicated to cardiac imaging. Patients
were scanned in supine position with the arms positioned over
the head. Patients with high uptake of 99mTc-tetrofosmin in the
abdomen were rescanned after intake of water and a walk to
avoid activity in the abdomen in the images. ECG-gated
images were acquired using 8 bins for both cameras. No
correction for scatter or attenuation was performed. The
images were reconstructed on a dedicated workstation
(Xeleris, GE Healthcare). All images were reconstructed and
reformatted into the standard axes (short axis, vertical long
axis, horizontal long axis), and polar maps of the left ventricle
were created.
CZT camera. Acquisition on the CZT camera after
stress was made with a scan time of 475 seconds based on the
study by Herzog et al.22 A 15% symmetrical energy window at
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140 keV was used. The images were reconstructed with an
iterative reconstruction algorithm. For gated stress images,
Maximum Likelihood Estimation Method (MLEM) 30 itera-
tions and Green OSL regularization alpha 0.4 and beta 0.4
were used and the images were postfiltered with a Butterworth
filter with cut-off frequency of 0.4 and power 10. For the
nongated stress images, MLEM 40 iterations and Green OSL
regularization alpha parameter of 0.51 and a beta of 0.3 were
used and the images were postfiltered with a Butterworth filter
with a cut-off frequency of 0.37 and a power of 7. All
reconstruction parameters used followed the recommendations
from the manufacturer. The images on the CZT camera were
acquired in list mode, which enables the images to be
resampled into a shorter acquisition via the list mode tool
Lister (Xeleris, GE Healthcare). Images for a subgroup of eight
patients with a body weight over 110 kg (the patients admin-
istered with fixed activities) were resampled into an acquisition
time that would correspond to an administered activity of
2.5 MBq/kg.
Conventional gamma camera. Acquisition on
the conventional gamma camera after stress was performed
with the detectors in L-mode using a 64 9 64 matrix and a
20% symmetrical energy window over the 140 keV photon
peak. Sixty (60) projections were acquired in a total angular
range of 180 degrees with a stop condition of 25 seconds per
projection. The images acquired on the conventional gamma
camera were reconstructed with a resolution recovery OSEM
algorithm (Evolution, GE Healthcare) with 12 iterations and 10
subsets and postfiltered with a Butterworth filter with a cut-off
frequency of 0.4 and a power of 10 in stress. A second
acquisition with a shorter time per angle to correspond to an
administered activity of 2.5 MBq/kg body weight was per-
formed on a subgroup of eight patients with a body weight over
110 kg.
Image Analysis
The total number of counts in the left ventricle was
derived for all studies by delineating the ventricle by automatic
segmentation. The number of counts in the acquired images,
Cacq, for both cameras was recalculated to correspond to the
number of counts that would have been acquired if the
administered activity would have been 2.5 MBq/kg, C2.5MBq/kg
(Eq. 1). mpatient is the patient’s body weight and A0 is the
administered activity to the patient.




For a subgroup of 16 patients (8 examined on CZT and 8
examined on conventional gamma camera), the image quality
(qualitative and quantitative) for the images of the current
administration schedule and for images corresponding to an
administered activity of 2.5 MBq/kg was evaluated. Two
experienced observers reviewed the images in a randomized
order. The readers were blinded to each other and all patient
data as well as to if the data set were current administration
schedule with fixed activities or 2.5 MBq/kg. The image
quality was visually graded according to a four-point scale
(1 = poor, 2 = adequate, 3 = good, 4 = excellent). The fol-
lowing variables were considered when grading the image
quality: noise level, the homogeneity of uptake as seen on both
the tomographic short- and long-axis slices and on the polar
plot representation. For quantification of ischemia, summed
stress score was manually determined. The analysis was
performed based on the 17-segment model of the left ventri-
cle23 using the myocardial perfusion SPECT module in the
software Segment as previously described.24
The total number of counts in the left ventricle was
derived also for the rest images. The counts from the stress
examination were decay-corrected and subtracted from the rest
image. In the same way as for the stress image, the counts from
the rest images were recalculated to correspond to the number
of counts that would have been acquired if the administered
activity would have been 3.1 MBq/kg, (Eq. 1). 3.1 MBq/kg is
clinically used for rest examination since the uptake in the
ventricle is lower in rest than in stress. For the patients
examined with a two-day protocol was the number of counts
recalculated to correspond to an injected activity of 3.1 MBq/
kg.
Dosimetry
The mean absorbed dose to whole body ( D) as a function
of body weight was calculated for our current clinical
administration schedule, administered activity according to
body weight (2.5 MBq/kg), the activity recommended by the
ASNC (444 MBq for patients below 70 kg, 444 MBq ?
11.5 MBq/kg body weight for patients over 70 kg)25 and by
the European Association of Nuclear Medicine (EANM)
(500 MBq)15 (Eq. 2). The residence time (s, the number of
decays in whole body per administered activity) for 99mTc-
tetrofosmin was taken from the International Commission on
Radiological Protection (ICRP) publication 106.26 The S value
(absorbed dose to whole body per decay in the whole body)
was scaled according to body weight (mpatient). The adminis-
tered activity to the patient is denoted A0. The mass of the
phantom for which the original S value was determined
(mphantom) equals to 73 kg.




The data are presented as mean ± SD. To test for
differences in number of counts between 4 and 2.5 MBq/kg,
a paired t test was used. To test for differences with regards to
image quality and summed stress score, the Wilcoxon signed-
rank test was used. Statistical significance was defined as
p\ 0.05.
RESULTS
All 200 patients successfully underwent a stress
examination, 82 by exercise and 118 by pharmacologic.
Thirty-three (33) of the patients had a body weight over
120 kg (BMI 31-58), 36 patients had a body weight
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between 110 and 120 kg (BMI 32-42), and 131 patients
had a body weight below 110 kg (BMI 18-41). The
injected activities were (mean ± SD) 2.57 ± 0.21 MBq/
kg, 413 ± 29 MBq and 583 ± 53 MBq at stress for the
three weight protocols\110, 110-120, and[120 kg,
respectively. Ninety-eight (98) of the patients (50
patients with a body weight\110 kg (BMI mean 29),
19 between 110 and 120 kg (BMI mean 37), and 29 with
a weight[120 kg(BMI mean 42) were examined on the
conventional gamma camera and 102 patients (81
patients with a body weight\110 kg (BMI mean 29),
17 between 110 and 120 kg (BMI mean 36), and 4 with
a weight[120 kg (BMI mean 34) on the CZT camera
(Table 1). Patient characteristics are shown in Table 2.
NUMBER OF COUNTS
The total numbers of reconstructed counts in the left
ventricle for the stress examination on the CZT camera
were 1.63E5 ± 0.37E5, 2.21E5 ± 0.76E5, and
2.99E5 ± 0.61E5 for patients\110 kg, 110-120 kg,
and[120 kg, respectively (Figure 1A). The
recalculation of the total number of counts to correspond
to an injected activity of 2.5 MBq/kg for two patient
groups[110 kg administered with fixed activities was
1.58E5 ± 0.43E5 for the CZT camera, which did not
differ significantly from the number of counts in
patients\110 kg (p = 0.63; Figure 1B). Recalculating
the counts in the left ventricle for the rest examination to
correspond to an injected activity of 3.1 MBq/kg
showed no statistical difference between patients[
110 kg and patients\110 kg (p = 0.59, Figure 1C).
The total numbers of reconstructed counts for the
stress examination on the conventional gamma camera
were 4.29E5 ± 1.48E5, 5.94 ± 1.40E5, and 8.26 ± 2.96
E5 for patients\110, 110-120, and[120 kg, respec-
tively (Figure 2A). Recalculating the total number of
counts corresponding to an administered activity of
2.5 MBq/kg for the two patient groups[110 kg resulted
in a number of counts of 4.42E5 ± 1.43E5 for the
conventional gamma camera, which did not differ from
the number of counts in patients\110 kg (p = 0.24)
(Figure 2B). The recalculation of counts in the left
ventricle for the rest examination to correspond to an
Table 1. The table shows the number of patients in the three different weight groups and on which
camera their images were acquired [body mass index (BMI)]. In total were 200 patients included in this
study




50 (18–41, mean 29) 19 (32–42, mean 37) 29 (31–58, mean 42) 98 (18–58, mean 34)
CZT camera (BMI) 81 (21–36, mean 29) 17 (31–43, mean 36) 4 (31–37, mean 34) 102 (21–36, mean 30)
Total BMI 131 (18–41, mean 29) 36 (31–43, mean 36) 33 (31–58, mean 41) 200 (18–58, mean 32)
Table 2. Baseline characteristics of all included patients (N or mean ± SD)
Exercise stress (n 5 82) Pharmacological stress (n 5 118)
Age (years) 64 ± 10 66 ± 10
Male 56 (68%) 87 (74%)
Female 26 (32%) 31 (26%)
BMI (kg/m2) 31 ± 7 (21–52) 33 ± 7 (18–58)
Body weight (kg) 94 ± 22 (55–156) 102 ± 23 (51–193)
Diabetes 16 (20%) 42 (36%)
Hyperlipidemia 38 (46%) 60 (51%)
Hypertension 46 (56%) 79 (67%)
Smoking 55 (67%) 88 (75%)
Family history of CAD 28 (34%) 45 (38%)
History of MI 21 (26%) 35 (30%)
PCI 21 (26%) 37 (31%)
CABG 9 (2%) 23 (19%)
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injected activity of 3.1 MBq/kg showed no statistical
difference between patients[110 kg and patients
\110 kg (p = 0.14; Figure 2C).
The acquisition of the stress examination was under-
taken at a mean of 56 minutes after the injection for
exercise and 67 minutes after the injection for pharma-
cological stress. For the conventional camera, the counts
in the myocardium were 5.29E5 ± 2.63E5 and
4.50E5 ± 2.65E5 for exercise and pharmacological
stress, respectively (p value = 0.16). For the CZT cam-
era, the counts in the myocardium were 1.90E5 ± 5.96E4
and 1.69E5 ± 5.64E4 for exercise and pharmacological
stress, respectively (p value = 0.07).
IMAGE QUALITY AND ISCHEMIA SCORE
Sixteen of the patients with a body weight over
110 kg (112-193 kg, BMI 31-58) were reimaged in the
conventional gamma camera, or alternatively, and the
listmode files from the CZT camera were resampled to
create images that correspond to an injected activity of
2.5 MBq/kg. The scores of the image quality for the two
reviewers are shown in Table 3. The mean value of the
evaluated image quality for the two administration
schedules was equal (p = 1.0). Examples of the image
quality for the current administration protocol and a
liner protocol of 2.5 MBq/kg can be seen in Figure 3.
There was no significant difference in SSS (summed
stress score) (p = 0.27) for quantification of ischemia
when comparing images reconstructed to reflect 4 MBq/
kg (median 2.0, range 0-36) with images reconstructed
to reflect 2.5 MBq/kg (median 3.5, range 0-35;
bias ± SD = 1.1 ± 3.5). The interobserver variability
of SSS was 0.7 ± 1.8.
Radiation Exposure
Figure 4 shows the mean absorbed dose to whole
body as a function of body weight when administered
according to the ASNC guidelines, the EANM guide-
lines, our current activity administration schedule, and
for an administration of 2.5 MBq/kg.
bFigure 1. The total number of reconstructed counts in the left
ventricle on the CZT camera for the A current activity
administration schedule at stress (\110 kg: 2.5 MBq/kg, 110-
120 kg: 430 MBq,[120 kg: 570 MBq), B if 2.5 MBq/kg
would have been administered at stress, and C if 3.1 MBq/kg
would have been administrated at rest.
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The effective dose for the stress examination using
a linear administration schedule of 2.5 MBq/kg body
weight for a 120 kg patient would decrease from
4.0 mSv (570 MBq) to 2.1 mSv (300 MBq) in stress.
DISCUSSION
This study shows that it is possible to use a linear
administration schedule of 2.5 MBq/kg body weight for
MPS on patients with a body weight ranging from 51 kg
to 193 kg (BMI 18-58) using a CZT gamma camera or a
conventional gamma camera with a resolution recovery
reconstruction algorithm. This will significantly reduce
the effective dose to the patient compared to the EANM/
ASNC guidelines.
The findings in the present study show that the
traditional proportionally higher administered activity or
prolonged acquisition time for obese patients is not
necessary for MPS. The higher proportion of attenuation
and scattered photons in fat tissue had no detectable in-
fluence on image quality and ischemia quantification.
Therefore, an administration schedule based on a linear
increase of activity, 2.5 MBq/kg, can be used also for
obese patients without loss of counts due to attenuation.
Using an administration schedule of 2.5 MBq/kg
reduces the radiation dose with 30% in stress compared
to the clinically used protocol for a 120 kg patient.
Reducing the administered activity is not only beneficial
for the patient but also advantageous for the staff taking
care of the patient.
Millions of MPS studies are performed each year
worldwide. Thus, reducing the administered activity will
result in a decreased collective dose, both for patients
and staff, and consequently a decreased risk associated
with ionizing radiation exposure. Reducing the admin-
istered activity may also be important to prolong the use
of MPS in the predicted worldwide deficiency of 99mTc.
Examining obese patients with the GE Discovery
530 CZT camera has been reported to be challeng-
ing21,27 due to the limited quality field of view (QFOV)
associated with this camera. For patients with a large
body habitus, it may be difficult to obtain an
bFigure 2. The total number of counts in the left ventricle for
the conventional gamma camera for the A current activity
administration schedule at stress (\110 kg: 2.5 MBq/kg, 110-
120 kg: 430 MBq,[120 kg: 570 MBq), B if 2.5 MBq/kg
would have been administered at stress, and C if 3.1 MBq/kg
would have been administrated at rest.
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acceptable position of the myocardium within the
QFOV, where an off center position may introduce
artifacts in the images.28 Therefore, it is important to
show that a linear administration schedule of 2.5 MBq/
kg in obese patients can be used also for conventional
MPS as has been shown in the present study. This is also
valid for patients with large breasts that have to be
examined with conventional MPS cameras for the same
reason as above.29 It is difficult to triage if it will be
possible to correctly position the patient by body weight
or BMI but an experienced technologist can by visual
inspection of the patient determine if a correct position
will be possible as long as the heart is normally
positioned in the body.
Using a linear schedule for administered activity in
the stress examination will according to this protocol
give an administered activity in the rest examination that
is also linear to the body weight. For a 2-day protocol,
the result from the stress examination found in this study
could potentially also be used for the rest examination
with a linear weight-based schedule.
LIMITATIONS
The findings in the present study should be inter-
preted in the light of limitations. Only a few patients
(n = 4) with a weight[120 kg were examined on the
CZT camera (17 patients with a body weight between
110 and 120 were included). This was due to the fact
that most of these patients could not be examined in this
camera because the heart could not be positioned within
the fixed QFOV related to the body habitus of these
patients.
NEW KNOWLEDGE GAINED
Linear low-dose administration of 99mTc-tetrofos-
min for MPS is feasible over a wide range of body
weights including obese patients for examination not
only with new generation of gamma cameras, CZT, but
also using a conventional gamma camera applying the
new generation of reconstruction algorithms taking into
account depth-dependent OSEM-Resolution Recovery.
Table 3. The result of the image quality for the current administration schedule with fixed activity
(110-120 kg: 430 MBq,[120 kg: 570 MBq) and for images corresponding to an administered activity
of 2.5 MBq/kg in 16 patients (112-193 kg, BMI 31-58). The first eight patients were examined on a
convention gamma camera, BMI 34-58, and the last eight on a CZT camera, BMI 31-38






1 3 3 3 2
2 3 4 2 3
3 3 4 3 3
4 4 3 3 2
5 3 4 2 3
6 2 2 2 1
7 4 3 3 3
8 3 3 2 2
9 3 3 3 3
10 3 3 2 3
11 4 4 4 4
12 4 3 4 3
13 3 3 3 3
14 4 3 3 3
15 3 4 3 4
16 4 4 4 4
Mean: 3.3 3.3 2.9 2.9
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CONCLUSIONS
A linear administration schedule of 2.5 MBq/kg
body weight can be applied for MPS of patients within a
wide range of body weight (51-193 kg, BMI 18-58)
using either a CZT gamma camera or a conventional
gamma camera with a resolution recovery reconstruction
algorithm. Thus, the radiation dose associated with MPS
can be significantly reduced in obese patients.
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Figure 3. The image quality (stress examination) for two patients administered with 431 MBq
(scanned on the CZT camera) and 433 MBq (scanned on the conventional gamma camera),
according to the current protocol. The scanning was performed to current protocol (475 seconds for
the CZT and 25 seconds/projection on the convention gamma camera) and with a reduced scan time
to correspond to an administered activity of 2.5 MBq/kg.
Figure 4. Mean absorbed dose from the stress examination to
whole body as a function of body weight for administered
activity at stress according to ASNC guidelines, EANM
guidelines, our current clinical activity administration sched-
ule, and 2.5 MBq/kg.
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